| Detailed information |
|---|
| CancerLivER ID | 2199 |
| Biomarker | MTHFR |
| Biomarker Name/Symbol (given in Publication) | MTHFR |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Candidate prognostic biomarkers for HCC recurrence in liver transplant recipients and validated on independent dataset |
| Experimental Condition | Normal vs HCC; predict recurrence in patients |
| Cancer type | Hepatocellular carcinoma |
| Regulation | MTHFR polymorphism was associated with HCC occurrence |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 29185200 |
| Type of Biomarker | Prognostic |
| Pathway | NA |
| Cohort | 244 HCC and 487 healthy individuals |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2018 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |